The company behind weight loss-aiding drugs Wegovy and Ozempic has warned it could accelerate its expansion in the United States if new regulations aimed at reforming Europe's pharmaceutical sector are brought in.
The European Union has proposed a reform to the bloc’s pharmaceutical legislation, which would aim to increase competition among drugmakers in Europe and improve access to medication across the EU’s 27 member states.
